ICMR clarifies on use of anti-HIV drugs on coronavirus-affected patients

Published On 2020-03-13 11:00 GMT   |   Update On 2020-03-13 11:00 GMT

New Delhi: Health ministry officials said on Thursday the decision to administer a combination of anti-HIV drugs -- lopinavir and ritonavir -- on a coronavirus-infected elderly Italian couple at a Jaipur hospital was "initially taken locally". The hospital has been asked to inform the health ministry and the Indian Council of Medical Research (ICMR) before administering the drug combination...

Login or Register to read the full article

New Delhi: Health ministry officials said on Thursday the decision to administer a combination of anti-HIV drugs -- lopinavir and ritonavir -- on a coronavirus-infected elderly Italian couple at a Jaipur hospital was "initially taken locally".

The hospital has been asked to inform the health ministry and the Indian Council of Medical Research (ICMR) before administering the drug combination on COVID-19 patients in future, officials said.

It was the first time that a combination of the two drugs was used to treat Covid-19 patients amid mounting coronavirus cases in India. The Italian couple are currently undergoing treatment at SMS Hospital in Jaipur.

"The decision to administer lopinavir and ritonavir combination initially was taken locally as they thought it was a severe disease and started the medicine. But we should not draw more conclusions from the same because single patient experiments do not reveal the truth more often. We need to have a structured study," Raman R Gangakhedkar, the head of the Epidemiology and Communicable Diseases-I at ICMR, said.

"Until we have a large data that come from such experiments we won''t be able to infer more. But since the drug was administered we have pressed into a study mode where the samples are being regularly collected in order to see if the drug was efficacious," he said.

Dr S Meena, the medical superintendent of SMS Hospital, said the decision to administer the combination of lopinavir and ritonavir was taken after the Italian man and his wife had developed severe respiratory problems.

The Italian man, who himself is a doctor, is in ICU and on oxygen support, Meena said, adding his condition is stable.

Read Also: COVID 19: Kerala CM asks PM Modi to withdraw compulsory certificate circular for Indians stranded in Italy

"Even before he acquired the infection, he had some respiratory issues. Also, he is a chronic smoker. His condition had deteriorated and he developed severe respiratory problems after getting the coronavirus infection and thus was given these drugs. his condition is stable.

"His wife who also had tested positive for coronavirus has recovered and has been shifted to a different hospital," Dr Meena said.

The Drug Controller General of India (DCGI) had approved the ''restricted'' use of the combination of medications, lopinavir and ritonavir, which are second-line HIV drugs, before they were administered to the elderly couple. The DCGI had given the approval after the Indian Council of Medical Research (ICMR) had sought an emergency approval for using the drugs for treating COVID- 19.

The number of coronavirus patients in the country has risen to 74. The figure includes 17 foreigners -- 16 Italian tourists and a Canadian. It also includes three patients from Kerala who were discharged last month following recovery.

Read Also: Gulbarga, Ballari get labs for testing samples of COVID-19


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News